Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Blood|November 22, 2014
Fc-optimized antibodies quickly pull the triggerChristian Kellner, Matthias Peipp
Oncoimmunology|July 30, 2013
Promoting natural killer cell functions by recombinant immunoligands mimicking an induced self phenotypeChristian Kellner, Martin Gramatzki, Matthias Peipp
Methods (San Diego, Calif.)|July 16, 2013
Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functionsChristian Kellner, Stefanie Derer, Thomas Valerius, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Fc engineering: design, expression, and functional characterization of antibody variants with improved effector functionStefanie Derer, Christian Kellner, Sven Berger, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 27, 2017
Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer TherapyChristian Kellner, Anna Otte, Elisa Cappuzzello, et al.
Oncoimmunology|September 18, 2018
Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemiaChristian Kellner, Matthias Peipp, Martin Gramatzki, et al.
Clinical and Experimental Immunology|March 24, 2022
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancerMatthias Peipp, Katja Klausz, Ammelie Svea Boje, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 12, 2014
Fc engineering of antibodies and antibody derivatives by primary sequence alteration and their functional characterizationStefanie Derer, Christian Kellner, Thies Rösner, et al.
Oncoimmunology|May 8, 2015
Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicityDaniel Gonnermann, Hans-Heinrich Oberg, Christian Kellner, et al.
Oncotarget|September 23, 2015
HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicityMatthias Peipp, Stefanie Derer, Stefan Lohse, et al.
Pageof 15